Prenetics Global (PRE) Common Equity (2021 - 2026)

Prenetics Global (PRE) has reported Common Equity for 6 consecutive years, with $92.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Common Equity fell 38.42% year-over-year to $92.9 million in Q2 2026; TTM through Jun 2026 was $92.9 million, a 38.42% decrease from a year earlier, with the FY2025 full-year figure at $156.4 million, down 8.74% from the prior year.
• Common Equity was $92.9 million for Q2 2026 at Prenetics Global, down from $121.0 million in the prior quarter.
• Over five years, Common Equity peaked at $243.5 million in Q4 2022 and troughed at -$424.9 million in Q1 2022.
• A 5-year average of $151.5 million and a median of $185.5 million in 2024 frame the typical range for Common Equity.
• Across the five-year window, Common Equity surged 160.74% in 2022 and sank 38.42% in 2026, its largest moves.
• Over 5 years, Common Equity stood at $243.5 million in 2022, then slipped by 13.68% to $210.2 million in 2023, then declined by 18.47% to $171.3 million in 2024, then dropped by 8.74% to $156.4 million in 2025, then slumped by 40.57% to $92.9 million in 2026.
• The last three Common Equity figures came in at $92.9 million (Q2 2026), $121.0 million (Q1 2026), and $156.4 million (Q4 2025), per Business Quant data.